Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD34+ Selection in Allogeneic Stem Cell Transplantation
NCT01049854Phase 2Completed
- Sponsor
- New York Medical College
- Start
- Sep 2011
- Primary completion
- Nov 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CD34-selected hematopoietic stem cells in leukemia, lymphoma, bone marrow failure, immunodeficiency, histiocytosis, sponsored by New York Medical College. Started Sep 2011; status: completed.
02
Drugs
CD34-selected hematopoietic stem cells
03
Conditions
leukemialymphomabone marrow failureimmunodeficiencyhistiocytosis
Beyond the preview
Go deeper on NCT01049854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01049854.